Targeting ST2 expressing activated regulatory T cells in Kras-mutant lung cancer
Icing colour Oncogenic KRAS-mutant lung cancers remain treatment refractory.A better understanding of the immune response of KRAS-mutant lung cancers is required to facilitate the development of potential therapeutic strategies.Regulatory T cells (Tregs) are a subset of immune cells that promote tumor progression through suppressing anti-tumor immu